Stock screenerAll disclosures →
EDGAR →
CRVO
Conviction 4HealthcareScan · Thu, Jun 25, 2026Hanging man
CRVO$3.38+3.68%
ResistanceSupportVol 14Vol MA14 23.85M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +66.67%· 5 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price3.38
Change+3.68%
Gap+3.37%
Rel volume0.02×
Avg volume16.71M
Avg $ vol72.36M
SMA 203.19
SMA 503.46
SMA 2005.88
Price vs 50-2.19%
Price vs 200-42.53%
MA stackbearish
50/200 cross—
Supertrendup · 3.03
RSI (14)50
MACD hist0.08
MACD crossbull · 6d
Stoch %K / %D22 / 23
ADX (14)46
+DI / −DI56 / 13
RSI divergence—
MACD divergenceBullish
ATR %+22.69%
ADR %18.53%
52w high10.69
52w low2.25
From 52w high-68.38%
Above 52w low+50.22%
New 52w highNo
SqueezeOff
Bollinger width75.93%
%B0.58
Donchian pos22.01%
Donchian high7.81
Donchian low2.13
AVWAP (52w high)5.24
vs AVWAP high-35.54%
AVWAP (52w low)4.96
vs AVWAP low-31.82%
OBV trendUp
Chaikin MF (20)-0.47
Today vs 20d0.02×
Avg vol (14d)23.85M
Avg vol (20d)16.71M
Avg $ vol (20d)72.36M
Market cap31.29M
RS 3m (vs SPY)-29.09%
RS 6m (vs SPY)-64.84%
RS line new highNo
Trend template1/8
Technical rank23.9
1 week-11.29%
1 month+10.82%
3 months-16.34%
6 months-58.35%
1 year-50.37%
YTD-56.61%
P/E-1.16
P/B2.95
P/S7.81
P/FCF-1.31
EPS2,038,891.00
Div yield—
ROE-254.02%
ROA-178.43%
Debt/Eq0.00
Current3.25
EV/EBITDA-0.83
Gross margin-43.38%
Net margin-673.06%
Rev growth-58.86%
EPS growth-65.53%
Price target20.40
Target upside503.55%
Analyst ratingBuy
Institutional15.62%
Ent. value23.4M
Revenue0
Net income-7.96M
Gross profit0
Free cash flow-23.9M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out9.26M
Employees15
ListedTue, Jun 18, 1996
Free float5.89M
Float %63.7%
Short interest262.81K
Days to cover2.9d
Short volume57.3%
Squeeze score35 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.86 vs −$0.90
Last surprise+4.4% beat
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank23.9 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHanging man
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CRVO
No recent disclosed trades by Congress in CRVO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CRVO · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Gregoire Sylvie Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
BOGER JOSHUA S Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Hollingsworth Jane H Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Quigley David Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
ZAVRL FRANK Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Sabbagh Marwan Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
ALAM JOHN J CEO & President · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Poulton Jeffrey V. Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in CRVO · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.